首页> 外文期刊>Biochimica et biophysica acta. Bioenergetics >Uncoupling, metabolic inhibition and induction of mitochondrial permeability transition in rat liver mitochondria caused by the major long-chain hydroxyl monocarboxylic fatty acids accumulating in LCHAD deficiency
【24h】

Uncoupling, metabolic inhibition and induction of mitochondrial permeability transition in rat liver mitochondria caused by the major long-chain hydroxyl monocarboxylic fatty acids accumulating in LCHAD deficiency

机译:大鼠肝线粒体中主要长链羟基单羧酸脂肪酸累积在缺乏症肝线粒体中的脱悬,代谢抑制和诱导

获取原文
获取原文并翻译 | 示例
           

摘要

Patients with long-chain 3-hydroxy-acyl-CoA dehydrogenase (LCHAD) deficiency commonly present liver dysfunction whose pathogenesis is unknown. We studied the effects of long-chain 3-hydroxylated fatty acids (LCHFA) that accumulate in LCHAD deficiency on liver bioenergetics using mitochondrial preparations from young rats. We provide strong evidence that 3-hydroxytetradecanoic (3HTA) and 3-hydroxypalmitic (3HPA) acids, the monocarboxylic acids that are found at the highest tissue concentrations in this disorder, act as metabolic inhibitors and uncouplers of oxidative phosphorylation. These conclusions are based on the findings that these fatty acids decreased ADP-stimulated (state 3) and uncoupled respiration, mitochondrial membrane potential and NAD(P)H content, and, in contrast, increased resting (state 4) respiration. We also verified that 3HTA and 3HPA markedly reduced Ca2+ retention capacity and induced swelling in Ca2+-loaded mitochondria. These effects were mediated by mitochondrial permeability transition (MPT) induction since they were totally prevented by the classical MPT inhibitors cyclosporin A and ADP, as well as by ruthenium red, a Ca2+ uptake blocker. Taken together, our data demonstrate that the major monocarboxylic LCHFA accumulating in LCHAD deficiency disrupt energy mitochondrial homeostasis in the liver. It is proposed that this pathomechanism may explain at least in part the hepatic alterations characteristic of the affected patients. (C) 2015 Elsevier B.V. All rights reserved.
机译:长链3-羟基 - 酰基-CoA脱氢酶(LCHAD)缺乏患者通常存在肝功能障碍,其发病机制是未知的。我们研究了长链3-羟基化脂肪酸(LCHFA)在幼小大鼠的线粒体制剂中积聚在肝生物植物缺乏症中积聚的长链3-羟基化脂肪酸(LCHFA)。我们提供了强有力的证据,即3-羟基二氧化乙二(3HTA)和3-羟基丙基甲基(3HPA)酸,在该疾病中最高组织浓度下发现的一元羧酸,充当代谢抑制剂和氧化磷酸化的脱孔器。这些结论基于这些脂肪酸降低了刺激的(状态3)和未耦合的呼吸,线粒体膜电位和NAD(P)H含量的结果,并且相反,增加休息(状态4)呼吸。我们还验证了3HTA和3HPA显着降低了Ca2 +保留能力,并诱导Ca2 + -Load的线粒体溶胀。这些效果是通过线粒体渗透率转变(MPT)诱导的介导的,因为它们被典型的MPT抑制剂环孢菌素A和ADP完全预防,以及钌红色,Ca2 +摄取阻滞剂。我们的数据一起携带,表明,在Lchad缺乏症中积累的主要单羧酸LCHFA扰乱了肝脏中的能量线粒体稳态。提出,该土地机制可以至少部分地解释受影响患者的肝脏改变特征。 (c)2015 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号